My NCBI | Sign In
RSS Settings
  • Search: Dubé Michael[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 53

    1.

    Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.

    Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ; ACTG 5152s Study Team.

    J Clin Lipidol. 2008 Dec;2(6):464-471.PMID: 19956354 [PubMed]

    2.

    Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.

    Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, Stein JH; for the SABAR Study Team.

    AIDS. 2009 Nov 30. [Epub ahead of print]PMID: 19952712 [PubMed - as supplied by publisher]Related articles

    3.

    Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay.

    Kalra SP, Dube MG, Iwaniec UT.

    Peptides. 2009 May;30(5):967-73. Epub 2009 Feb 7.PMID: 19428775 [PubMed - indexed for MEDLINE]Related articles

    4.

    Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis.

    Malhotra A, Vashistha H, Yadav VS, Dube MG, Kalra SP, Abdellatif M, Meggs LG.

    Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H380-8. Epub 2008 Dec 5.PMID: 19060130 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

    Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH; ACTG 5152s Study Team.

    J Am Coll Cardiol. 2008 Aug 12;52(7):569-76.PMID: 18687253 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Genetic analysis implicates resistin in HIV lipodystrophy.

    Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, Dube MP.

    AIDS. 2008 Aug 20;22(13):1561-8.PMID: 18670214 [PubMed - indexed for MEDLINE]Related articles

    7.

    No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial.

    Dubé MP, Shen C, Greenwald M, Mather KJ.

    Clin Infect Dis. 2008 Aug 15;47(4):567-74.PMID: 18636958 [PubMed - indexed for MEDLINE]Related articles

    8.

    State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

    Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH.

    Circulation. 2008 Jul 8;118(2):198-210. Epub 2008 Jun 19. No abstract available. Erratum in: Circulation. 2008 Aug 5;118(6):e109. PMID: 18566320 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of HIV infection and antiretroviral therapy on the heart and vasculature.

    Dubé MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD; Working Group 3.

    Circulation. 2008 Jul 8;118(2):e36-40. Epub 2008 Jun 19. No abstract available. PMID: 18566318 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.

    Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR; AIDS Clinical Trials Group 384 and A5005s Study Teams.

    J Infect Dis. 2008 Mar 15;197(6):858-66. Erratum in: J Infect Dis. 2008 Jun 1;197(11):1630. PMID: 18419350 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin-deficient diabetic obese mice.

    Dube MG, Torto R, Kalra SP.

    Peptides. 2008 Apr;29(4):593-8. Epub 2008 Jan 17.PMID: 18325632 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot study.

    Gupta SK, Johnson RM, Saha C, Mather KJ, Greenwald ML, Waltz JS, Rehman J, Dubé MP.

    AIDS. 2008 Mar 12;22(5):653-5.PMID: 18317009 [PubMed - indexed for MEDLINE]Related articles

    13.

    Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.

    Dubé MP, Gorski JC, Shen C.

    Cardiovasc Toxicol. 2008 Mar;8(1):15-22. Epub 2008 Jan 3.PMID: 18172783 [PubMed - indexed for MEDLINE]Related articles

    14.

    Proteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study.

    Gupta SK, Mather KJ, Agarwal R, Saha CK, Considine RV, Dubé MP.

    J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):596-8. No abstract available. PMID: 17704684 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.

    Dubé MP, Komarow L, Mulligan K, Grinspoon SK, Parker RA, Robbins GK, Roubenoff R, Tebas P; Adult Clinical Trials Group 384.

    J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):508-14.PMID: 17589373 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.

    Dubé MP, Parker RA, Mulligan K, Tebas P, Robbins GK, Roubenoff R, Grinspoon SK.

    Clin Infect Dis. 2007 Jul 1;45(1):120-6. Epub 2007 May 22. Erratum in: Clin Infect Dis. 2007 Oct 1;45(7):941. PMID: 17554712 [PubMed - indexed for MEDLINE]Related articles

    17.

    Isomeric enhancement of davanone from natural davana oil aided by supercritical carbon dioxide.

    Coleman WM 3rd, Dube MF, Ashraf-Khorassani M, Taylor LT.

    J Agric Food Chem. 2007 Apr 18;55(8):3037-43. Epub 2007 Mar 27.PMID: 17385880 [PubMed - indexed for MEDLINE]Related articles

    18.

    Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.

    Dubé MP, Wu JW, Aberg JA, Deeg MA, Alston-Smith BL, McGovern ME, Lee D, Shriver SL, Martinez AI, Greenwald M, Stein JH; AIDS Clinical Trials Group A5148 Study Team.

    Antivir Ther. 2006;11(8):1081-9.PMID: 17302378 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Low abundance of NPY in the hypothalamus can produce hyperphagia and obesity.

    Dube MG, Kalra SP, Kalra PS.

    Peptides. 2007 Feb;28(2):475-9. Epub 2007 Jan 12. Review.PMID: 17222946 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.

    Boghossian S, Ueno N, Dube MG, Kalra P, Kalra S.

    Neurobiol Aging. 2007 Oct;28(10):1594-604. Epub 2006 Sep 29.PMID: 17011078 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    7 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity